Denosumab - Wikipedia
Denosumab, sold under the brand names Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and …
Denosumab (subcutaneous route) - Mayo Clinic
It is used to prevent bone problems in patients with multiple myeloma and bone metastases (cancer that has spread) from tumors. Denosumab is also used to treat giant cell tumor of the …
Prolia: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年5月29日 · Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to: Increase bone mass in women at …
Prolia Injection (Denosumab): Uses & Side Effects - Cleveland Clinic
DENOSUMAB (den oh sue mab) slows bone breakdown. Prolia is used to treat osteoporosis in women after menopause and in men, and in people who are taking corticosteroids for 6 …
Denosumab - StatPearls - NCBI Bookshelf
2024年2月28日 · Denosumab is a bone anti-resorptive drug used for the treatment of the following: FDA-Approved Indications. Prevention of skeletal-related events: Denosumab is …
Denosumab - Drugs.com
2024年1月21日 · What is denosumab? The Prolia brand of denosumab is used in adults to treat osteoporosis or bone loss in people who: are at high risk for broken bones; and. who cannot …
Prolia (denosumab) - Uses, Side Effects, and More - WebMD
2024年7月3日 · What is Prolia used for? Prolia (denosumab) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to …
Denosumab Injection: MedlinePlus Drug Information
When a denosumab injection product (Prolia, Jubbonti) is used to treat osteoporosis or bone loss, it is usually given once every 6 months. When a denosumab injection product (Wyost, Xgeva) …
Denosumab (Prolia, Xgeva) | Cancer information - Cancer …
Denosumab is a type of targeted drug called a monoclonal antibody. It is also known as Prolia and Xgeva. You pronounce denosumab as den-oh-sue-mab. It is a treatment for secondary bone …
Denosumab - NCI - National Cancer Institute
giant cell tumor of the bone that cannot be removed by surgery. It is used in adults and in adolescents whose bones have finished growing. These uses are approved for the Xgeva …
- 某些结果已被删除